CareCloud, Inc. (CCLD)

Over the past six months, CareCloud, Inc. has experienced several events impacting its stock price. In Q3 2025, CareCloud reported a significant increase in revenue and earnings per share, leading to an upgrade in full-year 2025 revenue expectations. The share price as of February 5, 2026, was $2.25, representing a decline of 44.85% from $4.08 on February 6, 2025. As of January 30, 2026, CareCloud's market capitalization was $114.90 million, a decrease of 3% over the past 30 days and 7.19% over the last 12 months. In the past three months, CareCloud insiders have sold more of their company's stock than they have bought.

CareCloud has noted a degree of predictable seasonality in its demand, expecting Q3 and Q4 to mirror the previous year's performance with modest increases. However, CareCloud's management is less focused on seasonality and more on achieving its overall full-year revenue target, which for fiscal year 2025 is projected to be between $111 million and $114 million.

CareCloud, Inc., founded in 2009, provides cloud-based healthcare IT solutions to simplify healthcare administration and enable providers to focus on patient care. The company offers a comprehensive platform designed to enhance operational efficiency and financial performance for medical practices of all sizes. Its major products and services include practice management, electronic health records, revenue cycle management, patient engagement/experience management, telehealth solutions, data analytics and reporting tools, digital health services, healthcare IT professional services and staffing, and AI-driven solutions.

CareCloud, Inc. is headquartered in Somerset, New Jersey, U.S., and primarily serves healthcare providers and hospitals across the United States. The company also has operations in Pakistan and Sri Lanka, employing approximately 4,000 workers worldwide.

CareCloud's brand reputation in the past year has been characterized by a focus on innovation, customer service, and adapting to the evolving healthcare regulatory landscape. The company reported a strong financial turnaround, launched an AI Center of Excellence, and reignited its acquisition strategy. In March 2025, the conversion of Series A preferred stock simplified its capital structure, removed substantial annual dividend obligations, and converted preferred shares into common stock, enhancing financial flexibility. Analysts generally hold a "Hold" consensus rating for CareCloud, with a predicted upside of 32.65% based on their 12-month stock forecasts.

CareCloud stock ownership is distributed among institutional investors, company insiders, and the general public. Institutional investors hold between 8.52% and 14.14% of the company's stock. Individual insiders own approximately 1.99% to 14.8% of the company's shares. Public companies and individual investors collectively possess the majority of shares, ranging from 73.5% to 89.49%.